Medip Lung
Unleash the value of your diagnostic or prognostic tests and A.I. algorithms for Lung cancer. Medip Lung provides a dynamic platform to simulate patient outcomes and measure cost-effectiveness, offering invaluable insights for your product's entire lifecycle
Request a DemoApplications
With Medip Lung you can calculate and show the value of your Lung product for every setting. Whether your client is a large hospital or small clinic, is in Europe or the US, the platform can calculate and show the value of your product.
Platform features
At each stage of your product cycle
Potential value
Showcase the potential value of your product to convince investors and receive grants for further development of your product.
Optimize value
Optimize the value of your product by setting the optimal threshold for a positive test.
Convey value
Demonstrate the value of your product to healthcare professionals, hospital management and payers in each context of interest
Medip Lung can be a valuable tool for many important stakeholders in the healthcare field.
Key Opinion Leaders (KOLs)
Secure the endorsement of Key Opinion Leaders in the field of Pulmonology and Radiology
Health care professionals
Convince Pulmonologists and Radiologists of the added value of your product within the Lung cancer pathway
Hospital Management
Show that your product provides value for money in the context of their specific hospital setting
Payers
Demonstrate the cost-effectiveness for the payer’s customer segment
Ready to unlock your product's potential?
Schedule a demo to see how Medip Lung can drive your product's development and market success.
Request a Demo